Fumihiro Kashizaki

8PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyGene and molecular therapyHuman biophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 22, 2026
Phase 3 Antifibrotic-Directed Therapy Outcomes in Idiopathic Pulmonary Fibrosis: Beyond FVC Decline.

|Jul 10, 2026
Impact of Prior Systemic Chemotherapy on Response to ROS1 Tyrosine Kinase Inhibitors in ROS1-Rearranged Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

|Jan 16, 2026
Radiotherapy Response Patterns in Thoracic NUT Carcinoma: A Case Report.

Fumihiro Kashizaki, Nanami Tsuchiya, Shohei Watanabe

|Aug 27, 2024
Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases.

Fumihiro Kashizaki, Sachiko Matsumoto, Atsushi Miyasaka

|May 07, 2024
Effective treatment of MET exon 14 skipping mutation-positive non-small cell lung cancer using capmatinib following serious maculopapular rash caused by two MET inhibitors: a case report.

Fumihiro Kashizaki, Shunsuke Okazaki, Nanami Tsuchiya

|Jan 02, 2024
Pretreatment asthma control test score as a predictive score for clinical remission after bronchial thermoplasty in younger patients with severe asthma and preserved lung function.

Fumihiro Kashizaki, Kenji Konishi, Hao Chen

Pageof 2

Frequent Collaborators

4 joint publications

Hao Chen

3 joint publications

Ryusuke Orii

3 joint publications

Harumi Koizumi

2 joint publications

Kentaro Yumoto